Bexin, Hustentropfen

7680396400153 CH-39640 Hustentropfen
Bexin, Hustentropfen
Bexin, Hustentropfen
Bexin, Hustentropfen
1 / 3
google

Article details

Package size
20
Selling units
20
Measure
ml
Galenic form
Hustentropfen
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/10/2022
Patient information leaflet
Français
03/10/2022
Patient information leaflet
Italien
03/10/2022
Summary of Product Characteristics
Allemand
03/10/2022
Summary of Product Characteristics
Français
03/10/2022
Summary of Product Characteristics
Italien
03/10/2022

Detailed composition

Substance Quantity Type Category
(N/A)
20.81 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HBESI
(N/A)
106.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance HIMDK
(N/A)
- Substance HIMDK
(N/A)
0.3 MG Substance HBESI
(N/A)
1.0 MG Substance HBESI
(N/A)
0.88 MG Substance HBESI

Reimbursement information

Public price
CHF 12.80
Specialties list
Yes
Generic
No
SL addition date: 15/03/1978

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
39640
Drug name
Bexin, Hustentropfen
Galenic form
TROL
ATC Code
R05DA09
Authorization status
Z
Dispensing category
B
First authorization
27/09/1976
Authorization expiration date
31/12/9999
IT Number
03.01.1.
Domain
Human medicine
Field of application
Husten

Package details

Description (FR)
BEXINE gouttes 20.8 mg/ml fl 20 ml
Description (DE)
BEXIN Tropfen 20.8 mg/ml Fl 20 ml
Market launch
27/09/1976
Narcotic (BTM)
No